Scudder SA - Search Results

1

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Lara PN Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Lara PN Jr, et al. Among authors: scudder sa. J Clin Oncol. 2001 Mar 15;19(6):1728-33. doi: 10.1200/JCO.2001.19.6.1728. J Clin Oncol. 2001. PMID: 11251003

2

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.

Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN Jr. Martel CL, et al. Cancer J. 2004 Sep-Oct;10(5):294-300. doi: 10.1097/00130404-200409000-00006. Cancer J. 2004. PMID: 15530258

3

Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.

Davies AM, Ho C, Beckett L, Lau D, Scudder SA, Lara PN, Perkins N, Gandara DR. Davies AM, et al. Among authors: scudder sa. J Thorac Oncol. 2009 Jul;4(7):862-8. doi: 10.1097/JTO.0b013e3181a94b08. J Thorac Oncol. 2009. PMID: 19494788 Free article. Clinical Trial.

4

Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study.

Perez EA, Scudder SA, Meyers FA, Tanaka MS, Paradise C, Gandara DR. Perez EA, et al. Among authors: scudder sa. J Immunother (1991). 1991 Feb;10(1):57-62. doi: 10.1097/00002371-199102000-00008. J Immunother (1991). 1991. PMID: 2012799

5

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.

Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM. Garcia AA, et al. J Clin Oncol. 2008 Jan 1;26(1):76-82. doi: 10.1200/JCO.2007.12.1939. J Clin Oncol. 2008. PMID: 18165643 Clinical Trial.

6

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2.

Meyers FJ, Paradise C, Scudder SA, Goodman G, Konrad M. Meyers FJ, et al. Among authors: scudder sa. Clin Pharmacol Ther. 1991 Mar;49(3):307-13. doi: 10.1038/clpt.1991.33. Clin Pharmacol Ther. 1991. PMID: 2007324 Clinical Trial.

7

Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin.

Lin A, Ryu J, Harvey D, Sieracki B, Scudder S, Wun T. Lin A, et al. Gynecol Oncol. 2006 Jul;102(1):98-102. doi: 10.1016/j.ygyno.2005.11.031. Epub 2006 Jan 10. Gynecol Oncol. 2006. PMID: 16406065

8

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.

Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK. Wun T, et al. Among authors: scudder sa. Cancer. 2003 Oct 1;98(7):1514-20. doi: 10.1002/cncr.11700. Cancer. 2003. PMID: 14508840 Free article.

9

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.

Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Schultheis AM, et al. Clin Cancer Res. 2008 Nov 15;14(22):7554-63. doi: 10.1158/1078-0432.CCR-08-0351. Clin Cancer Res. 2008. PMID: 19010874 Free PMC article. Clinical Trial.

10

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH. Morgan RJ Jr, et al. Int J Gynecol Cancer. 2007 Mar-Apr;17(2):373-8. doi: 10.1111/j.1525-1438.2007.00787.x. Int J Gynecol Cancer. 2007. PMID: 17362315 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters